These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24476520)

  • 21. Vascular endothelial growth factor C (VEGF-C) expression in pT2 gastric cancer.
    Tsutsumi S; Kuwano H; Shimura T; Morinaga N; Mochiki E; Asao T
    Hepatogastroenterology; 2005; 52(62):629-32. PubMed ID: 15816493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
    Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
    Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
    Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
    Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker.
    Sayar A; Turna A; Solak O; Kiliçgün A; Urer N; Gürses A
    Ann Thorac Surg; 2004 Feb; 77(2):421-5. PubMed ID: 14759409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous Invasion and Perineural Invasion as Upstaging and Poor Prognostic Factors in N0 Gastric Cancers.
    Chang K; Song B; DO IG; Koo DH; Lee HW; Son BH; Yoo CH; Kim K
    Anticancer Res; 2021 Nov; 41(11):5803-5810. PubMed ID: 34732454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ets-1 expression in gastric cancer.
    Tsutsumi S; Kuwano H; Nagashima N; Shimura T; Mochiki E; Asao T
    Hepatogastroenterology; 2005; 52(62):654-6. PubMed ID: 15816498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Che X; Iwashige H; Aridome K; Hokita S; Aikou T
    Cancer; 2000 Feb; 88(3):577-83. PubMed ID: 10649250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
    Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
    Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.
    Lee JH; Lee KG; Ryou H; Jun YJ; Paik SS; Park HK; Lee KS
    Hepatogastroenterology; 2010; 57(99-100):646-52. PubMed ID: 20698243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
    Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
    Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of perineural invasion in early-stage cervical cancer.
    Elsahwi KS; Barber E; Illuzzi J; Buza N; Ratner E; Silasi DA; Santin AD; Azodi M; Schwartz PE; Rutherford TJ
    Gynecol Oncol; 2011 Dec; 123(3):561-4. PubMed ID: 21968340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tumor vascular invasion in breast carcinoma. Hematoxylin-eosin versus immunohistochemical staining for factor VIII antigen].
    Obermair A; Czerwenka K; Kurz C; Kaider A; Sevelda P
    Dtsch Med Wochenschr; 1994 Nov; 119(44):1491-6. PubMed ID: 7525176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysis.
    Deng J; You Q; Gao Y; Yu Q; Zhao P; Zheng Y; Fang W; Xu N; Teng L
    PLoS One; 2014; 9(2):e88907. PubMed ID: 24586437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perineural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immunohistochemical enhancement.
    Kurtz KA; Hoffman HT; Zimmerman MB; Robinson RA
    Arch Pathol Lab Med; 2005 Mar; 129(3):354-9. PubMed ID: 15737030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100 Staining Adds to the Prognostic Significance of the Combination of Perineural Invasion and Lymphovascular Invasion in Colorectal Cancer.
    Conte GA; Qari O; Fasano GA; Guinto RK; Palo L; Parker GS; Rangwala AF; Minassian H; Greenberg PJ; Dewan AA; Topilow AA
    Appl Immunohistochem Mol Morphol; 2020; 28(5):354-359. PubMed ID: 30585786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
    Kim KC; Koh YW; Chang HM; Kim TH; Yook JH; Kim BS; Jang SJ; Park YS
    Ann Surg Oncol; 2011 Oct; 18(10):2833-40. PubMed ID: 21468783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
    Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
    Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy.
    De Dosso S; Zanellato E; Nucifora M; Boldorini R; Sonzogni A; Biffi R; Fazio N; Bucci E; Beretta O; Crippa S; Saletti P; Frattini M
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):159-65. PubMed ID: 23645290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.